Sensex
73,852.90 profit arw -876.37 (-1.17%)
Nifty
22,888.95 profit arw -257.20 (-1.11%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Enter a 10 digit mobile number starting with 7, 8, or 9
Captcha verification code, enter the characters shown below

As on : 16-Oct-2026
Corporate News
16-Oct-2026     00:44

Mankind Pharma to acquire 70% stake in Armed Cell Therapeutics for EUR 48 million

Mankind Pharma announced it will acquire a 70% stake in Belgium-incorporated biotechnology company Armed Cell Therapeutics B.V. (ACTx) through its Netherlands subsidiary, Mankind Pharma (Netherlands) B.V., for a consideration of EUR 48 million. The acquisition, part of Mankind Pharma’s strategy to build a global innovation-led pharmaceutical business, will be funded through an additional investment of up to EUR 45 million in Mankind Pharma (Netherlands) B.V., increasing the aggregate investment limit to EUR 50 million. ACTx is developing next-generation chimeric antigen receptor T-cell (CAR-T) therapies for cancer, with lead programs targeting non-Hodgkin lymphoma and small cell lung cancer.

INDIAN INDICES

Sensex

73,852.90 -876.37 (-1.17%)

Nifty

22,888.95 -257.20 (-1.11%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

24,180.40 117.67(0.49%)